Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Gefitinib therapy can cause unusual hair growth on the nose.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

Some drugs can cause permanent hair loss, though it's rare.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

EGFR inhibitors for lung cancer can cause severe skin issues.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Cetuximab can cause skin cysts after acne-like eruptions.

Google should ban ads targeting cancer patients with sensitive health-related keywords to protect them from misleading information.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

A rare skin cancer was correctly diagnosed after surgery, highlighting the need for careful examination and follow-up.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

Alkaloids show promise in treating cholangiocarcinoma by effectively targeting cancer cells.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.